Articles Tagged With:
-
Abuse and Harassment in the OR
Managers should assess whether their policies and procedures are strong enough to produce an adequate response when staff members or patients report these incidents.
-
FDA Actions
In this section: boxed warning to all immediate-release opioids; eased restrictions on mifepristone used with misoprostol used for medical abortions; reslizumab for the maintenance treatment of severe asthma; and ixekizumab for the treatment of adults with moderate-to-severe plaque psoriasis.
-
New Guidelines for Dual Antiplatelet Therapy
The guideline recommends a minimal therapy duration of 6-12 months, while therapy beyond 12 months should be reserved for patients at the highest risk of a vascular event.
-
More Evidence Supports Timing Hypothesis for Hormone Therapy
More evidence that supports the timing hypothesis (or the critical window-of-opportunity hypothesis) for hormone therapy to slow atherosclerosis progression.
-
Federal Agencies, States Move Swiftly to Combat Opioid Overdose Epidemic
CDC issues new pain management guidelines; White House, states bring own ideas to the table.
-
More Research Links Zika to Microcephaly
Experts seem more certain than ever about this suspected fear.
-
Safe Injection Practices and IV Push Guidelines: Compliance with CDC and CMS Standards
Is your hospital prepared and up-to-date with safe injection practices? Would you pass the survey?
AHC Media can help. -
New Study: Unhappy Physicians Cut Back Workhours
Concerned about the physician shortage? Then keep your physicians happy. -
ED Push - April 2016 First Issue
-
Chest Pain and Giant T Wave Inversion
Chest pain (rather than shortness of breath) and ST elevation (rather than T wave inversion) in leads V1 and V2 make massive pulmonary embolism unlikely.